- Topics
- Regions
- Events
- Webcasts
- Resources
- CW Exclusives
- Membership
“For tracking litigation, enforcement, and regulatory developments, Compliance Week
should be your prime source.”- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
U.S. Appeals Court overturns Nasdaq board diversity rule
By 
Aaron Nicodemus2024-12-13T17:55:00
A U.S. Appeals Court overturned a Securities and Exchange Commission (SEC) rule that had required companies listed on the Nasdaq stock exchange to disclose whether their boards had women or minority members–and if not, why not.
The decision, handed down Wednesday by the U.S. Court of Appeals for the Fifth Circuit, said that the SEC and Nasdaq rule was not related to the core purposes of the Securities Exchange Act of 1934.
“The proposal instead represented an attempt by Nasdaq and SEC to use their ‘leverage over market participants’ to remedy a societal challenge that bore no relation to ‘the authority granted them in the Exchange Act,’” the decision said.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefFederal judge overturns FTC’s ban on noncompete clauses
A federal judge struck down the ban on noncompete clauses by the Federal Trade Commission that was set to take effect in September.
-
PremiumSCOTUS overturns Chevron doctrine, putting thousands of regulations in limbo
The Supreme Court of the United States overturned a long-held precedent in which courts deferred to federal agencies in interpreting complex or ambiguous regulations–a decision that could make thousands of federal regulations more vulnerable to legal challenges.
-
PremiumCourt overturns SEC private fund adviser rule, calls out agency overreach
A federal appeals court struck down the Securities and Exchange Commission’s private fund adviser rule, agreeing with industry advocates that the agency overstepped its authority.
More from Regulatory Policy
-
News BriefFDA bans Red No. 3 dye after decades of concerns over possible health risks
The U.S. Food and Drug Administration announced Wednesday it has revoked authorization for color additive Red No. 3 from food, beverages, and drugs. Health concerns over dye have existed since it was banned from cosmetics in 1990 after it was found that large doses led to the development of cancer ...
-
News BriefNew CFPB payment privacy rule on the way for gaming companies, cryptocurrencies, Big Tech
The Consumer Financial Protection Bureau has issued a proposed rule aimed at protecting the privacy of the public when using novel digital payment systems, such as those offered by large technology platforms and video gaming companies.
-
News BriefCFPB rule bans lenders from using medical debt in credit report determinations
Banks and other lenders will be prohibited from using medical debt information in credit reports, under a new rule finalized by the Consumer Financial Protection Bureau, the agency said.